Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status

Susan E. McCann; Swati Kulkarni; Maurizio Trevisan; Dominica Vito; Jing Nie; Stephen B. Edge; Paola Muti; Jo L. Freudenheim

doi:10.1007/s10549-006-9196-x

Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status

Susan E. McCann^*, Swati Kulkarni, Maurizio Trevisan, Dominica Vito, Jing Nie, Stephen B. Edge, Paola Muti, Jo L. Freudenheim

^*Corresponding author for this work

Surgery, Breast Surgery Division

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Abstract

We examined the association of dietary lignan intake with estrogen receptor negative (ER-) and ER positive (ER+) breast cancer risk in a breast cancer case-control study. Among premenopausal women only, there was a reduced risk of ER- breast cancer for those in the highest compared to the lowest quartile of lignan intake suggesting that the observed negative association of lignans with breast cancer may be limited to ER- tumors.

Original language	English (US)
Pages (from-to)	309-311
Number of pages	3
Journal	Breast Cancer Research and Treatment
Volume	99
Issue number	3
DOIs	https://doi.org/10.1007/s10549-006-9196-x
State	Published - Oct 1 2006

Keywords

Breast cancer
Estrogen receptor
Lignans
Phytoestrogens

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1007/s10549-006-9196-x

Fingerprint Dive into the research topics of 'Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status'. Together they form a unique fingerprint.

Cite this

@article{972cbceedcc2447fb7a6356b132bc64d,

title = "Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status",

abstract = "We examined the association of dietary lignan intake with estrogen receptor negative (ER-) and ER positive (ER+) breast cancer risk in a breast cancer case-control study. Among premenopausal women only, there was a reduced risk of ER- breast cancer for those in the highest compared to the lowest quartile of lignan intake suggesting that the observed negative association of lignans with breast cancer may be limited to ER- tumors.",

keywords = "Breast cancer, Estrogen receptor, Lignans, Phytoestrogens",

author = "McCann, {Susan E.} and Swati Kulkarni and Maurizio Trevisan and Dominica Vito and Jing Nie and Edge, {Stephen B.} and Paola Muti and Freudenheim, {Jo L.}",

year = "2006",

month = oct,

day = "1",

doi = "10.1007/s10549-006-9196-x",

language = "English (US)",

volume = "99",

pages = "309--311",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "3",

}

TY - JOUR

T1 - Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status

AU - McCann, Susan E.

AU - Kulkarni, Swati

AU - Trevisan, Maurizio

AU - Vito, Dominica

AU - Nie, Jing

AU - Edge, Stephen B.

AU - Muti, Paola

AU - Freudenheim, Jo L.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - We examined the association of dietary lignan intake with estrogen receptor negative (ER-) and ER positive (ER+) breast cancer risk in a breast cancer case-control study. Among premenopausal women only, there was a reduced risk of ER- breast cancer for those in the highest compared to the lowest quartile of lignan intake suggesting that the observed negative association of lignans with breast cancer may be limited to ER- tumors.

AB - We examined the association of dietary lignan intake with estrogen receptor negative (ER-) and ER positive (ER+) breast cancer risk in a breast cancer case-control study. Among premenopausal women only, there was a reduced risk of ER- breast cancer for those in the highest compared to the lowest quartile of lignan intake suggesting that the observed negative association of lignans with breast cancer may be limited to ER- tumors.

KW - Breast cancer

KW - Estrogen receptor

KW - Lignans

KW - Phytoestrogens

UR - http://www.scopus.com/inward/record.url?scp=33748360278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748360278&partnerID=8YFLogxK

U2 - 10.1007/s10549-006-9196-x

DO - 10.1007/s10549-006-9196-x

M3 - Article

C2 - 16541305

AN - SCOPUS:33748360278

VL - 99

SP - 309

EP - 311

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -